It is almost the end of the year. With the exception of a few, many of the biotech stocks, like the following, on which investors had bet big this year have served up only heartbreak. Now, let's take a look at some of the pending clinical trial catalysts of this month, which will make it a December to remember.
from RTT - Biotech http://ift.tt/2g9Sxus
via IFTTT
No comments:
Post a Comment